Rappsilber Juri, Bruce James, Combe Colin, Fried Stephen D, Graziadei Andrea, Heck Albert J R, Iacobucci Claudio, Leitner Alexander, Mechtler Karl, Novak Petr, O'Reilly Francis, Schriemer David C, Sinz Andrea, Stengel Florian, Thalassinos Konstantinos
Technische Universität Berlin, Chair of Bioanalytics, Berlin, Germany; Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK; Si-M/""Der Simulierte Mensch"", a Science Framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Mol Cell Proteomics. 2025 Jun 26;24(8):101024. doi: 10.1016/j.mcpro.2025.101024.
Crosslinking mass spectrometry (MS) can uncover protein-protein interactions and provide structural information on proteins in their native cellular environments. Despite its promise, the field remains hampered by inconsistent data formats, variable approaches to error control, and insufficient interoperability with global data repositories. Recent advances, especially in false discovery rate models and pipeline benchmarking, show that crosslinking MS data can reach a reliability that matches the demand of integrative structural biology. To drive meaningful progress, however, the community must agree on error estimation, open data formats, and streamlined repository submissions. This perspective highlights these challenges, clarifies remaining barriers, and frames practical next steps. Successful field harmonization will enhance the acceptance of crosslinking MS in the broader biological community and is critical for the dependability of the data, no matter where it is produced.
交联质谱(MS)能够揭示蛋白质-蛋白质相互作用,并在天然细胞环境中提供蛋白质的结构信息。尽管前景广阔,但该领域仍受到数据格式不一致、误差控制方法各异以及与全球数据存储库的互操作性不足的阻碍。最近的进展,特别是在错误发现率模型和流程基准测试方面,表明交联质谱数据能够达到与整合结构生物学需求相匹配的可靠性。然而,为了推动有意义的进展,该领域必须就误差估计、开放数据格式和简化存储库提交达成共识。本观点强调了这些挑战,阐明了剩余的障碍,并规划了切实可行的下一步措施。成功的领域协调将提高交联质谱在更广泛生物学界的接受度,并且对于数据的可靠性至关重要,无论数据在何处产生。